070473543	070473543	CD	B-NP	O
|	|	NN	I-NP	O
MPH	MPH	NN	I-NP	O
|	|	NN	I-NP	O
61438117	61438117	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4741365	4741365	CD	B-NP	O
|	|	CC	I-NP	O
1/12/2005	1/12/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
;	;	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/12/2005	6/12/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2005	10/22/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LINNERT	LINNERT	NNP	B-NP	O
,	,	,	O	O
EMMETT	EMMETT	NNP	B-NP	O
581-39-64-7	581-39-64-7	CD	I-NP	O
Delaware	Delaware	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/24/05	5/24/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOWTHORP	LOWTHORP	NNP	B-NP	O
,	,	,	O	O
CODY	CODY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
DIGOXIN	DIGOXIN	NNP	I-NP	I-protein
0.125	0.125	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ENALAPRIL	ENALAPRIL	NNP	I-NP	I-protein
MALEATE	MALEATE	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	B-ADJP	O
90	90	CD	B-NP	O
;	;	:	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-ADJP	O
50	50	CD	B-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
GABAPENTIN	GABAPENTIN	NN	I-NP	B-protein
100	100	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q24H	Q24H	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
5	5	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Starting	Start	VBG	B-VP	I-protein
Today	Today	NN	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
11/24	11/24	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

LANTUS	LANTUS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
22	22	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/28	7/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3	3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
*******	*******	SYM	B-NP	O
NEEDS	NEEDS	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
AT	AT	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
CLINIC	CLINIC	NNP	I-NP	O
*******	*******	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Ballsherm	Ballsherm	NNP	I-NP	O
W.all	W.all	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/21/05	5/21/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
AINCA	AINCA	NNP	B-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
,	,	,	O	O
NH	NH	NN	B-NP	B-protein
PCP	PCP	NN	I-NP	I-protein
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Duncan	Duncan	NNP	I-NP	O
Tambunga	Tambunga	NNP	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
,	,	,	O	O
Isleburg	Isleburg	NNP	B-NP	O
Jackfairm	Jackfairm	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
have	have	VBP	B-VP	O
first	first	JJ	B-NP	O
INR	INR	NN	I-NP	O
check	check	NN	I-NP	O
7/30/05	7/30/05	CD	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/30/05	7/30/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2-3	2-3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Gatall	Gatall	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
Failure	Failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
;	;	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CMP	CMP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diuresis	Diuresis	NNP	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
medication	medication	NN	I-NP	O
optimization	optimization	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
71	71	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
new-onset	new-onset	JJ	I-NP	O
CM	CM	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
EF15	EF15	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
metastatic	metastatic	JJ	I-NP	O
BCA	BCA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
3	3	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
taxol	taxol	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
herceptin	herceptin	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
SOB	SOB	NN	I-NP	O
following	follow	VBG	B-PP	O
chemo	chemo	NN	B-NP	O
this	this	DT	B-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
CM	CM	NN	I-NP	O
1/19/05	1/19/05	CD	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
month	month	NN	I-NP	O
prior	prior	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
beginning	begin	VBG	B-VP	O
taxol	taxol	NN	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	B-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
swelling	swell	VBG	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
some	some	DT	B-NP	O
cough	cough	NN	I-NP	O
lying	lie	VBG	B-VP	O
down	down	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
chest	ch	JJS	I-NP	O
CT	CT	NN	I-NP	B-protein
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
10/10	10/10	CD	B-NP	O
showed	show	VBD	B-VP	O
interval	interval	JJ	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
LAsix	LAsix	NN	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
fill	fill	VB	I-VP	O
the	the	DT	B-NP	O
presciption	presciption	NN	I-NP	O
till	till	RB	B-NP	O
4/29	4/29	CD	I-NP	O
An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
at	at	IN	B-PP	O
Greepe	Greepe	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
LV	LV	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
PT	PT	NN	B-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
KMC	KMC	NN	B-NP	B-cell_type
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w/anticoagulation	w/anticoagulation	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
bridged	bridge	VBD	B-VP	O
to	to	TO	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Had	Have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
Adenosine-MIBI	Adenosine-MIBI	NNP	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
though	though	IN	B-SBAR	I-protein
non	non	JJ	B-NP	I-protein
diagnostic	diagnostic	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
negative	negative	JJ	B-NP	O
labs	lab	NNS	I-NP	O
for	for	IN	B-PP	O
CM	CM	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
following	follow	VBG	B-PP	O
diuresis	diuresis	NN	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condtion	condtion	NN	I-NP	O
,	,	,	O	O
stating	state	VBG	B-VP	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
walk	walk	VB	I-VP	O
1/2	1/2	CD	B-NP	O
mile	mile	JJ	I-NP	O
w/out	w/out	NN	I-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
F/C	F/C	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
chemotherapty	chemotherapty	NN	B-NP	O
this	this	DT	B-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
recieving	recieve	VBG	B-VP	O
Taxol	Taxol	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
requisite	requisite	JJ	I-NP	O
NaCl	NaCl	NN	I-NP	O
load	load	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
become	become	VBP	B-VP	O
acutely	acutely	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
rales	rale	NNS	B-NP	O
to	to	TO	B-PP	O
apex	apex	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
,	,	,	O	O
MSo4	MSo4	NN	B-NP	B-protein
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
E	E	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
sating	sate	VBG	B-VP	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RR32	RR32	NN	B-NP	B-protein
,	,	,	O	O
HR140	HR140	NN	B-NP	B-cell_line
,	,	,	O	O
BP137/82	BP137/82	NN	B-NP	B-protein
,	,	,	O	O
T97	T97	NN	B-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
50	50	CD	B-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
trop	trop	NN	B-NP	O
0.27	0.27	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	B-DNA
325	325	CD	I-NP	I-DNA
,	,	,	O	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
?	?	.	O	O

RLL	RLL	NN	B-NP	O
PNA	PNA	NN	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
1	1	CD	B-NP	O
dose	dose	NN	I-NP	O
Levo	Levo	NNP	B-NP	O
500mg	500mg	CD	I-NP	O
and	and	CC	O	O
10U	10U	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
BS684	BS684	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
P110	P110	NN	B-NP	B-protein
,	,	,	O	O
BP130/80	BP130/80	NN	B-NP	B-protein
,	,	,	O	O
RR26	RR26	NN	B-NP	B-protein
,	,	,	O	O
Sating	Sate	VBG	B-VP	O
98	98	CD	B-NP	O
3L	3L	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Metastatic	Metastatic	JJ	B-NP	O
Breast	Breast	NNP	I-NP	O
CA	CA	NNP	I-NP	O
,	,	,	O	O
CM	CM	NNP	B-NP	O
,	,	,	O	O
LV	LV	NNP	B-NP	O
THrombus	THrombus	NNP	I-NP	O
,	,	,	O	O
HTn	HTn	NNP	B-NP	O
,	,	,	O	O
DM	DM	NNP	B-NP	O
FH	FH	NNP	I-NP	O
:	:	:	O	O
Mother	Mother	IN	B-PP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
DM	DM	NN	I-NP	O
;	;	:	O	O
SH	SH	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
occl	occl	NN	B-NP	O
drinks	drink	VBZ	B-VP	O
Exam	Exam	NNP	B-NP	O
:	:	:	O	O
102130/70	102130/70	CD	B-NP	O
;	;	:	O	O
24	24	CD	B-NP	O
;	;	:	O	O
99	99	CD	B-NP	O
3l	3l	NN	I-NP	O
;	;	:	O	O
JVP	JVP	NN	B-NP	O
10-11cm	10-11cm	NN	I-NP	O
,	,	,	O	O
Tachy	Tachy	NNP	B-NP	O
,	,	,	O	O
warm	warm	JJ	B-NP	O
,	,	,	I-NP	O
-	-	HYPH	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
RLL	RLL	NN	B-NP	O
Infiltrate	Infiltrate	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
Interval	Interval	JJ	I-NP	O
change	change	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
Unchanged	Unchanged	JJ	B-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
Na	Na	NN	B-NP	B-protein
129	129	CD	I-NP	I-protein
,	,	,	O	O
Gluc	Gluc	NN	B-NP	B-protein
684	684	CD	I-NP	I-protein
,	,	,	O	O
Trop	Trop	NNP	B-NP	O
.27	.27	CD	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
.61	.61	CD	B-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
734	734	CD	I-NP	I-protein
,	,	,	O	O
AlkPh170	AlkPh170	NNP	B-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
10.35	10.35	CD	I-NP	O
,	,	,	O	O
1Band	1Band	NN	B-NP	B-protein
UA	UA	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
+	+	SYM	I-NP	O
BAct	BAct	NN	I-NP	O
,	,	,	O	O
2nd	2nd	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	CD	B-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Continued	Continued	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
80qd	80qd	NN	I-NP	O
;	;	:	O	O
I/O	I/O	NN	B-NP	O
;	;	:	O	O
Weights	Weight	NNS	B-NP	O
;	;	:	O	O
Replete	Replete	NNP	B-NP	O
Lytes	Lytes	NNP	I-NP	O
,	,	,	O	O
Continued	Continued	NNP	B-NP	O
Ace	Ace	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
watch	watch	VBP	B-VP	O
renal	renal	JJ	B-NP	B-protein
function	function	NN	I-NP	I-protein
stable	stable	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
initially	initially	RB	B-ADVP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
,	,	,	O	O
Continued	Continued	NNP	B-NP	O
BB	BB	NNP	I-NP	O
,	,	,	O	O
Dig	Dig	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Echo	Echo	RB	B-NP	O
performed	perform	VBN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
interval	interval	JJ	I-NP	O
change	change	NN	I-NP	O
since	since	IN	B-PP	O
4/20	4/20	CD	B-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
no	no	DT	B-NP	O
LV	LV	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Check	Check	NNP	B-NP	O
TFT	TFT	NNP	I-NP	O
's	's	POS	B-NP	O
-LRB-	-LRB-	JJ	I-NP	O
Last	Last	JJ	I-NP	O
TSH	TSH	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-ADVP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
Cath	Cath	NNP	B-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
CAD	CAD	NN	B-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
esp	esp	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
+	+	SYM	B-NP	O
trop	trop	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
Starting	Start	VBG	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
STATIN	STATIN	NN	B-NP	B-protein
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
BB	BB	NNP	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
on	on	IN	B-PP	O
for	for	IN	B-PP	O
PTT	PTT	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
50-70	50-70	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
ACE	ACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
watch	watch	VBP	B-VP	O
renal	renal	JJ	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Trending	Trend	VBG	B-VP	O
trop/ekg	trop/ekg	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
May	May	MD	B-VP	O
be	be	VB	I-VP	O
+	+	SYM	B-ADJP	O
from	from	IN	B-PP	O
flash	flash	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Consider	Consider	VB	B-VP	O
cath	cath	NN	B-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
pending	pende	VBG	B-VP	O
attd	attd	NN	B-NP	O
.	.	.	O	O

NPO	NPO	NN	B-NP	B-protein
after	after	IN	B-PP	O
mid	mid	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Tele	Tele	NNP	B-NP	O
;	;	:	O	O
Sinus	Sinus	NNP	B-NP	O
tach	tach	NN	I-NP	O
-	-	HYPH	B-VP	O
continued	continue	VBN	B-NP	O
BB	BB	NN	I-NP	O
;	;	:	O	O
Considered	Consider	VBN	B-VP	O
increasing	increase	VBG	B-NP	O
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
simulatneous	simulatneous	JJ	B-ADJP	O
with	with	IN	B-PP	O
ACE	ACE	NN	B-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
drops	drop	NNS	B-NP	O
in	in	IN	B-PP	O
bp	bp	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
Continued	Continued	NNP	B-NP	O
Diuresis	Diuresis	NNP	I-NP	O
for	for	IN	B-PP	O
Flash	Flash	NNP	B-NP	O
Edema	Edema	NNP	I-NP	O
.	.	.	O	O
?	?	.	O	O

PNA	PNA	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
CXR	CXR	NN	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
LEvo	LEvo	NNP	B-NP	O
500qd	500qd	CD	I-NP	O
X	X	NN	I-NP	O
7days	7day	NNS	I-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
therapy	therapy	NN	I-NP	O
provided	provide	VBD	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
BUN/Cre	BUN/Cre	NN	B-NP	O
>	>	SYM	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Hyaline	Hyaline	NN	B-NP	O
casts	cast	NNS	I-NP	O
present	present	VBP	B-VP	O
.	.	.	O	O

Watch	Watch	NN	B-NP	O
urine	urine	NN	I-NP	O
output/cre	output/cre	NN	I-NP	O
for	for	IN	B-PP	O
pre-renal	pre-renal	JJ	B-NP	O
;	;	:	O	O
Not	Not	RB	B-ADJP	O
likely	likely	RB	I-ADJP	O
UTI	UTI	NN	B-NP	O
given	give	VBN	I-NP	O
2nd	2nd	NN	I-NP	O
neg	neg	NN	I-NP	O
UA	UA	NNP	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
TFT	TFT	NN	B-NP	O
's	'	VBZ	B-VP	O
persistently	persistently	RB	B-NP	O
low	low	JJ	I-NP	O
TSH	TSH	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
otherwise	otherwise	JJ	I-NP	O
nl	nl	NN	I-NP	O
values	value	NNS	I-NP	O
X	X	SYM	B-ADJP	O
2	2	CD	B-NP	O
--	--	:	O	O
Watch	Watch	NN	B-NP	O
for	for	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
;	;	:	O	O
DIABETES	DIABETES	NN	B-NP	O
:	:	:	O	O
:	:	:	O	O
Initially	Initially	RB	B-NP	O
continued	continue	VBN	I-NP	O
Home	Home	NNP	I-NP	O
insulin	insulin	NN	I-NP	O
regimin	regimin	NN	I-NP	O
but	but	CC	O	O
given	give	VBN	B-NP	O
sugars	sugar	NNS	I-NP	O
inthe	inthe	VBP	B-VP	O
300-400	300-400	CD	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
Lantis	Lantis	NNP	B-NP	O
to	to	TO	B-PP	O
***	***	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SS	SS	NN	I-NP	O
coverage	coverage	NN	I-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
meals	meal	NNS	I-NP	O
,	,	,	O	O
Her	Her	PRP$	B-NP	O
pre-chemo	pre-chemo	JJ	I-NP	O
decadrone	decadrone	NN	I-NP	O
may	may	MD	B-VP	O
make	make	VB	I-VP	O
glucose	glucose	NN	B-NP	O
control	control	NN	I-NP	O
difficult	difficult	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
may	may	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
formal	formal	JJ	I-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
is	be	VBZ	B-VP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

FEN	FEN	NNP	B-NP	O
:	:	:	O	O
Checked	Check	VBN	B-NP	O
lytes	lyte	NNS	I-NP	O
;	;	:	O	O
Low	Low	JJ	B-NP	O
NA	NA	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
Low	Low	JJ	B-NP	O
fat/Low	fat/Low	NN	I-NP	O
chol	chol	NN	I-NP	O
;	;	:	O	O
Fluid	Fluid	NN	B-NP	O
restrict	restrict	NN	I-NP	O
<	<	SYM	B-NP	O
2L	2L	NN	I-NP	O
*	*	SYM	I-NP	O
HOSP	HOSP	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
diuresed	diurese	VBN	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
sx	sx	NN	B-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

D/C	D/C	NN	B-NP	O
'd	'd	MD	B-VP	O
home	home	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
HF	HF	NN	B-NP	B-protein
,	,	,	I-NP	O
ONC	ONC	NN	I-NP	B-protein
and	and	CC	I-NP	O
COumadin	COumadin	NN	I-NP	O
F/U	F/U	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
Complete	Complete	VB	I-VP	O
levo	levo	FW	B-NP	O
course	course	NN	I-NP	O
outpt	outpt	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
3	3	CD	I-NP	O
remaining	remain	VBG	I-NP	O
doses	dose	NNS	I-NP	O
-RRB-	-RRB-	IN	B-PP	O
ADDITIONAL	ADDITIONAL	NN	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
closely	closely	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
SPHO	SPHO	NN	I-NP	B-protein
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
for	for	IN	B-PP	O
successful	successful	JJ	B-NP	O
optimization	optimization	NN	I-NP	O
of	of	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
eat	eat	VB	I-VP	O
low	low	JJ	B-NP	O
NA	NA	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
Watch	Watch	NNP	B-NP	O
fluid	fluid	VBD	B-VP	O
intake	intake	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
<	<	NNP	I-NP	O
2L/day	2L/day	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
take	take	VB	B-VP	O
prescribed	prescribe	VBN	B-NP	O
medications	medication	NNS	I-NP	O
regularly	regularly	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
to	to	TO	B-VP	O
gain	gain	VB	I-VP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
Diabetes	Diabetes	NNP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
increased	increase	VBN	I-VP	O
your	your	PRP$	B-NP	O
lantus	lantus	NN	I-NP	O
dose	dose	NN	I-NP	O
so	so	RB	O	O
please	please	VB	B-VP	O
monitor	monitor	NN	B-NP	O
glucose	glucose	NN	I-NP	O
frequently	frequently	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
monitored	monitor	VBN	B-VP	O
for	for	IN	B-PP	O
Theraputic	Theraputic	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
AVNER	AVNER	NNP	B-NP	O
,	,	,	O	O
DEANGELO	DEANGELO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TK920	TK920	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/24/05	5/24/05	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

